Details for New Drug Application (NDA): 204613
✉ Email this page to a colleague
The generic ingredient in CIPROFLOXACIN HYDROCHLORIDE is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 204613
Tradename: | CIPROFLOXACIN HYDROCHLORIDE |
Applicant: | Altaire Pharms Inc |
Ingredient: | ciprofloxacin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 204613
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204613 | ANDA | Altaire Pharmaceuticals Inc. | 59390-217 | 59390-217-02 | 2.5 mL in 1 BOTTLE, PLASTIC (59390-217-02) |
CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204613 | ANDA | Altaire Pharmaceuticals Inc. | 59390-217 | 59390-217-05 | 5 mL in 1 BOTTLE, PLASTIC (59390-217-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.3% BASE | ||||
Approval Date: | May 3, 2018 | TE: | AT | RLD: | No |
Complete Access Available with Subscription